Not only is atrial fibrillation (AFib) of serious concern for affected people, but it is also a burden to the healthcare system, needing long-term treatment and management to address its rapidly increasing prevalence. AFib care costs nearly $15,000 annually in incremental direct and indirect costs per person. To reduce healthcare costs and hospitalization rates and improve quality of life, innovative treatments such as the hybrid maze procedure aim to manage AFib without relying on repeat treatments such as radiofrequency ablation therapy, cardioversions (ongoing electrical manipulation of heart rate) or continued adjustment of medications.
Continue Learning about Atrial Fibrillation
Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.